VitaminAlly Joint Nourish liquid recalled over manufacturing practice deviations
VitaminAlly Joint Nourish oral liquid is being recalled over deviations from current Good Manufacturing Practices that could lead to bacterial pathogen contamination and possible C. botulinum concerns.
The agency’s classification
FDA (Food): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall where the manufacturing deviations are described as potentially leading to bacterial pathogen contamination, a named risk of harm with no illnesses reported.
Plain-English summary
Joint Nourish, an oral liquid supplied in a 480 ml plastic bottle with a 2 tablespoon (30 ml) dose, from VitaminAlly LLC of Chandler, Arizona, is being recalled. The action covers 90 bottles.
The stated reason is deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen contamination and possible C. botulinum concerns. The FDA classified the action as Class II.
The affected lot is JN0925, expiry 09/2027, distributed between 1 October 2025 and 8 April 2026. Distribution was nationwide and to Puerto Rico.
Consumers who have the affected lot should stop using it and dispose of it or return it to the place of purchase. Anyone who has used it and feels unwell should contact a healthcare provider.
The recalled product
- Product
- Joint Nourish. Dosage:2 tablespoons (30mL). Liquid. For Oral use. Packaging: Plastic Bottle. Net Volume:480 ml. Firm Address: VitaminAlly LLC Chandler, AZ 85225.
- Manufacturer
- Wellnov Supplements LLC
- Category
- Food — Dietary supplement
- Affected units
- 90
Distribution
Part of a larger recall action
This product is one of 14 recalled by Wellnov Supplements LLC under a single FDA (Food) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Wellnov Supplements LLC
See all →- HighVitaminAlly iron-free women's multivitamin drops recalled over manufacturing deviations
FDA (Food) · 2026-05-27
- HighVitaminAlly liposomal D3 and B12 spray recalled over manufacturing deviations
FDA (Food) · 2026-05-27
- HighVitaminAlly womens 50+ multivitamin drops recalled over manufacturing deviations
FDA (Food) · 2026-05-27
- HighVitaminAlly kids liquid multivitamin drops recalled over manufacturing deviations
FDA (Food) · 2026-05-27
- HighVitaminAlly liposomal B12 spray recalled over manufacturing practice deviations
FDA (Food) · 2026-05-27
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereFDA Recalls Vitamin D3 Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2019-04-24
- SevereRanier's Compounding Laboratory Recalls Vitamin D3 Injection Due to Sterility Concerns
FDA (Drugs) · 2018-08-22
- HighVitamin D3 50,000IU Compounded Product Recalled for Sterility Assurance Failure
FDA (Drugs) · 2022-07-20
- ModerateGM Manufacturing Recalls Bone & Joint Plus Dietary Supplements
FDA (Food) · 2014-08-06
- HighVitamin B-Complex Injectable Vials Recalled for Lack of Sterility
FDA (Drugs) · 2022-07-20
- LowApotex Recalls Azelastine Hydrochloride Nasal Solution Due to CGMP Deviations
FDA (Drugs) · 2012-09-05